ADVERTISEMENT

Partnered Video

Sponsored by :

Adalvo: Interview With CEO Anil Okay

Watch now as Adalvo CEO Anil Okay shares with Citeline his perspectives on the rapidly-growing European B2B’s recent acquisition by private equity firm EQT. Find out what it means for the business, and how it may reflect wider pharma trends, in this insightful video interview.

Sponsored by :

Inside ICROM: A New Era for HPAPIs and Advanced Crystallization

ICROM on Flexibility, HPAPIs, and the Future of CDMO Services

Sponsored by:

Meeting the demands of the global biologics market

Lonza is addressing the growing global demand for biologics by utilizing its expert teams and the advanced capabilities of its newly acquired large-scale manufacturing site in Vacaville, California. Joanna McCafferty, Director of Commercial Development, shares more in this brief video. Ask ChatG

Sponsored by:

Oncology R&D trends at a glance: Biotechs share key insights

Biotechs focus on novel cancer therapies to address the rising global burden. Yet, oncology R&D poses unique, complex challenges. Overcoming these while adapting to an evolving landscape is key to transforming patient care and improving outcomes.